You can buy or sell MRKR and other stocks, options, ETFs, and crypto commission-free!
Marker Therapeutics, Inc. Common Stock, also called Marker Therapeutics, is an immuno-oncology company, which engages in the development of technologies for the treatment of cancer, including metastasis, and infectious diseases. Read More It also involves in developing vaccines for breast, colorectal, ovarian, and non-small cell lung cancer. The company was founded in 1991 and is headquartered in Houston, TX.
52 Week High
52 Week Low
Expected Mar 21, After Hours